These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2945696)
41. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582 [TBL] [Abstract][Full Text] [Related]
42. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783 [TBL] [Abstract][Full Text] [Related]
43. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence. Paccaud JP; Carpentier JL; Schifferli JA Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082 [TBL] [Abstract][Full Text] [Related]
44. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137 [TBL] [Abstract][Full Text] [Related]
45. C3b receptor (CR1) on erythrocytes in various diseases. Takemura S; Deguchi M; Ueda M; Yoshida N; Kato H; Yoshikawa T; Sugino S; Kondo M Immunol Lett; 1984; 7(6):325-8. PubMed ID: 6233222 [TBL] [Abstract][Full Text] [Related]
46. Deficiency of erythrocyte C3b receptor (CR1) in AIDS and AIDS-related syndromes. Tausk FA; McCutchan JA; Schreiber RD; Spechko P; Gigli I Biosci Rep; 1986 Jan; 6(1):81-6. PubMed ID: 2938642 [TBL] [Abstract][Full Text] [Related]
47. Release of immune complexes bound to erythrocyte complement receptor (CR1), with particular reference to the role of factor I. Jepsen HH; Svehag SE; Jensenius JC; Sim RB Scand J Immunol; 1986 Aug; 24(2):205-13. PubMed ID: 2944215 [TBL] [Abstract][Full Text] [Related]
48. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon. Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925 [TBL] [Abstract][Full Text] [Related]
49. Proliferation of resting B cells is modulated by CR2 and CR1. Fingeroth JD; Heath ME; Ambrosino DM Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816 [TBL] [Abstract][Full Text] [Related]
50. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. Yoon SH; Fearon DT J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931 [TBL] [Abstract][Full Text] [Related]
51. Enhanced binding of immune complexes processed by erythrocyte CR1 (CD 35) receptors to purified CR2 (CD 21) receptors from tonsillar mononuclear cells. Rask R; Rasmussen JM; Jepsen HH; Svehag SE APMIS; 1989 Apr; 97(4):374-80. PubMed ID: 2524204 [TBL] [Abstract][Full Text] [Related]
52. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. Craig ML; Waitumbi JN; Taylor RP J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520 [TBL] [Abstract][Full Text] [Related]
53. Human complement receptors for C3b (CR1) and C3d (CR2). Fearon DT J Invest Dermatol; 1985 Jul; 85(1 Suppl):53s-57s. PubMed ID: 2989379 [TBL] [Abstract][Full Text] [Related]
54. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632 [TBL] [Abstract][Full Text] [Related]
55. Defective immune adherence receptors (CR1) on erythrocytes in autoimmune diseases: an association with HLA-Cw3. Matsumura Y; Inokuma S; Hayakawa T; Kisaki T Arthritis Rheum; 1985 Mar; 28(3):349-51. PubMed ID: 3156605 [No Abstract] [Full Text] [Related]
56. Low C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody. Minota S; Terai C; Nojima Y; Takano K; Takai E; Miyakawa Y; Takaku F Arthritis Rheum; 1984 Dec; 27(12):1329-35. PubMed ID: 6239627 [TBL] [Abstract][Full Text] [Related]
57. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Wilson JG; Ratnoff WD; Schur PH; Fearon DT Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021 [TBL] [Abstract][Full Text] [Related]
58. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Schifferli JA; Ng YC; Paccaud JP; Walport MJ Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842 [TBL] [Abstract][Full Text] [Related]
60. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. O'Shea JJ; Brown EJ; Seligmann BE; Metcalf JA; Frank MM; Gallin JI J Immunol; 1985 Apr; 134(4):2580-7. PubMed ID: 3156186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]